Exploring Next-Generation Payload Diversity Beyond Cytotoxics to Diversify Immune-oncology MOAs
Time: 9:15 am
day: Conference Day Two
Details:
- Exploring an internal preclinical pipeline of small molecule payloads with conjugation potential
- Discussing matching target biology with payload choice and unique considerations for contemporary ADC design
- Differentiating modes of action and identifying therapeutic niches based off-target
